HomeCompareSNCE vs JEPQ

SNCE vs JEPQ: Dividend Comparison 2026

SNCE yields 34.78% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SNCE wins by $129.0K in total portfolio value
10 years
SNCE
SNCE
● Live price
34.78%
Share price
$5.75
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$173.8K
Annual income
$26,108.19
Full SNCE calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — SNCE vs JEPQ

📍 SNCE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSNCEJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SNCE + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SNCE pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SNCE
Annual income on $10K today (after 15% tax)
$2,956.52/yr
After 10yr DRIP, annual income (after tax)
$22,191.96/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, SNCE beats the other by $20,362.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SNCE + JEPQ for your $10,000?

SNCE: 50%JEPQ: 50%
100% JEPQ50/50100% SNCE
Portfolio after 10yr
$109.3K
Annual income
$14,130.39/yr
Blended yield
12.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SNCE right now

SNCE
Analyst Ratings
1
Buy
3
Hold
Consensus: Hold
Altman Z
-3.2
Piotroski
4/9
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SNCE buys
0
JEPQ buys
0
No recent congressional trades found for SNCE or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSNCEJEPQ
Forward yield34.78%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$173.8K$44.8K
Annual income after 10y$26,108.19$2,152.59
Total dividends collected$125.1K$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: SNCE vs JEPQ ($10,000, DRIP)

YearSNCE PortfolioSNCE Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$14,178$3,478.26$11,930$1,110.39+$2.2KSNCE
2$19,780$4,608.94$14,133$1,224.34+$5.6KSNCE
3$27,173$6,009.16$16,632$1,340.46+$10.5KSNCE
4$36,791$7,715.34$19,454$1,457.97+$17.3KSNCE
5$49,129$9,762.64$22,626$1,576.08+$26.5KSNCE
6$64,752$12,183.73$26,175$1,694.09+$38.6KSNCE
7$84,292$15,007.57$30,133$1,811.32+$54.2KSNCE
8$108,451$18,258.34$34,531$1,927.17+$73.9KSNCE
9$137,997$21,954.52$39,403$2,041.08+$98.6KSNCE
10$173,765$26,108.19$44,787$2,152.59+$129.0KSNCE

SNCE vs JEPQ: Complete Analysis 2026

SNCEStock

Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.

Full SNCE Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this SNCE vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SNCE vs SCHDSNCE vs JEPISNCE vs OSNCE vs KOSNCE vs MAINSNCE vs XYLDSNCE vs QYLDSNCE vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.